To compare the safety and efficacy of two different surgical techniques of tumour resection in bladder cancer patients

Comparison of efficacy and safety of monopolar and bipolar transurethral resection of the bladder tumour in patients of bladder cancer : An open-label randomised control study

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2020/07/026680

Enrollment

150

Registered

2020-07-20

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C679- Malignant neoplasm of bladder, unspecified

Interventions

Intervention1: transurethral resection of bladder tumour: It will done using monopolar and bipolar electrode Control Intervention1: Transurethral resection of bladder tumour: Monopolar resection will

Eligibility

Inclusion criteria

Inclusion criteria: Patients with bladder tumours undergoing TURBT under regional anaesthesia

Exclusion criteria

Exclusion criteria: • Restage TURBT • Refusal to give informed consent • Contraindication of spinal anaesthesia

Design outcomes

Primary

Measure	Time frame
Obturator jerkTimepoint: Only during intra operative period	—

Secondary

Measure	Time frame
1. Safety of B-TURBT vs M-TURBT 2. Change in Haemoglobin, 3. Post-op hematuria 4. Need for blood transfusion, 5. Change in electrolytes, 6. TUR syndrome, 7. Bladder perforation 8. Quantity and quality of cautery artifacts in the tissue specimens in both the groups 9. Resection time, 10. Hospital stay. 11. Reoperation rate Timepoint: 1. Intraoperative 2. Postoperative(immediate) 3. Follow up after 3 weeks	—

Measure

Time frame

1. Safety of B-TURBT vs M-TURBT 2. Change in Haemoglobin, 3. Post-op hematuria 4. Need for blood transfusion, 5. Change in electrolytes, 6. TUR syndrome, 7. Bladder perforation 8. Quantity and quality of cautery artifacts in the tissue specimens in both the groups 9. Resection time, 10. Hospital stay. 11. Reoperation rate Timepoint: 1. Intraoperative 2. Postoperative(immediate) 3. Follow up after 3 weeks

—

Countries

India

Contacts

Public ContactDr Jyoti Mohan Tosh

AIIMS rishikesh

kjmammen@gmail.com9861292243

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026